Table 1.

Patient characteristics.

Recipient ID	1567	1599	1610	1619	1620
Original HSCT
Sex of recipient	Male	Female	Female	Female	Male
Age of recipient	2	20	59	43	53
HSCT indication	WASP	Sickle cell anemia	Acute myeloid leukemia	Acute lymphoid leukemia	Lymphoma
Serological status   Recipient/donor CMV	+/−	+/+	+/−	−/−	+/+
Serological status   Recipient/donor Toxoplasma	−/−	+/−	+/−	−/−	+/−
Serological status   Recipient/donor EBV	−/+	+/+	+/+	+/+	+/+
Serological status   Recipient/donor HSV1	+/−	−/−	−/+	+/−	−/−
Original graft	BM	BM	BM	BM	PBSC
Preconditioning	RIC	RIC	RIC	MAC	MAC
MUD/related donor	MUD	Sibling	MUD	MUD	MUD
GVHD status	(−)	(−)	(−)	(+)	(+)
Chimerism status prior to  booster	MC	DC	DC	DC	DC
Stem cell booster
Booster indication	Neutropenia  thrombocytopenia	Neutropenia  thrombocytopenia	Neutropenia  thrombocytopenia	Neutropenia  thrombocytopenia	Neutropenia  thrombocytopenia
Infectious problems	CMV	EBV  Mucositis	Toxoplasma	CMV, HSV1	CMV
Source of booster	PBSC	PBSC	BM	PBSC	PBSC
Day of booster	+434	+193	+134	+196	+176
Status 90 days	Alive	Alive	Alive	Alive	Alive
Status 6 months	Alive	Alive	Alive	Deceased	Alive
Response on  leucothrombopenia	(+)	(++)	(++)	(+)	(−)
Response on infectious  complications	(+)	(++)	(+)	(++)	(−)

WASP: Wiskott Aldrich syndrome, MAC: myeloablative conditioning, RIC: reduced intensity conditioning, MC: mixed chimeric, DC: donor chimeric, MUD: matched unrelated donor, GVHD: graft versus host disease (status prior to booster), CMV: cytomegalovirus, EBV: Epstein Barr virus, HSV: herpes simplex virus, PBSC: peripheral blood stem cells, and BM: bone marrow.